Table:
begin	end	state
1	18	cytoplasmic
19	53	transmembrane
54	60	cytoplasmic
61	75	transmembrane
76	107	cytoplasmic
108	132	transmembrane
133	137	non-cytoplasmic
138	162	transmembrane
163	168	cytoplasmic
169	188	transmembrane
189	201	non-cytoplasmic
202	220	transmembrane
221	252	cytoplasmic
253	279	transmembrane
280	317	non-cytoplasmic
318	342	transmembrane
343	353	cytoplasmic
354	380	transmembrane
381	385	non-cytoplasmic
386	405	transmembrane
406	410	cytoplasmic
411	429	transmembrane
430	464	non-cytoplasmic
465	487	transmembrane
488	501	cytoplasmic

Input:
>WP_042119327.1 NCBI__GCF_000092045.1:WP_042119327.1
MDLFSNLALGFATAATLDNLLFCLIGVLLGTLIGVLPGIGATATIAMLLPITFQLEPVSS
LIMLAGIYYGAQYGGSTTAILINMPGESSSAVTAIDGYQMARKGRAGAALAIAALGSFFA
GTVSTFLVAIFAPPLTDIALQFGSAEYFSLMIVGLVSSIALAHGSVVKALAMVALGLLLG
LVGTDIYTGTPRFTLGIREYADGLNFVALAVGVFGVAEILRNLEGESTRTVLMAKVSGLL
PSRQEFKEMIAPIIRGTAIGSALGILPGGGAILASFASYTVEKRLSKTPKEFGQGAVAGV
AGPESANNAGAQTSFIPLLTLGIPANPVMALMIGAMIIQGIVPGPNVATEQPALFWGIIA
SMWIGNLMLVILNLPLIGLWVKLLTVPYYVLFPIIMAFCSIGVYSVNSNVYDLYAVAFFG
LIGYVLAKLRCEPAPLLLGFVLGPLLEENLRRAMILSRGDPSTFITRPISATLLAIAVAV
LIVVFLPSVRKKREEVFVEEA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server